Therapeutics - Arrhythmias Part 2 Flashcards

1
Q

2 goals for rhythm control for afib

A

get to NSR
reduce patient’s symptoms

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

what is an “acute transition to NSR”

A

a cardioversion

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

2 general methods for rhythm control for afib

A

cardioversion or chronic meds

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

which 2 rhythm control drugs use the “pill in pocket” approach

A

flecainide, propafenone

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

the choice of anti arrhythmics for afib is severely limited by what

A

any heart disease

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

ONLY TWO antiarrhythmics that can be given to afib patients who also have MI, HF, or other structural heart disease

A

amiodarone, sotalol

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

general guideline on when to give anti ARRHYTHMICS for afib

A

if had afib for less than a year (if over a year – very hard to get back to normal sinus rhythm)

if the pt has concurrent heart failure

pt has persistent symptoms while on rate control

they are hemodynamically unstable

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

dose of flecainide/propafenone for pill in pocket approach

A

flecainide - 200-300mg once

propafenone - 450-900mg once

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

explain what the “pill in pocket” approach exactly is

A

patients self administered a dose when they feel symptoms

has been shown to reduce hospital admissions and costs - improved qol

HOWEVER, the patient must first be on an AV nodal blocking agent (otherwise, this approach can cause rapid av conduction and atrial flutter)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

sotalol contraindication

A

in creatinine clearance less than 40ml!

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

important monitoring parameter for sotalol (anti-arrhytmic)

A

monitor QT!!!!! for initial 3 days, and then every 3-6 months

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

patient’s creatinine clearance is 40-60mL/min

what is sotalol dosing

A

once a day

if below 40 - contraindicated!

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

true or false

amiodarone is very effective at maintaining normal sinus rhythm

A

true

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

monitoring recommendations for amiodarone ADRs

A

baseline: chest xray, liver fxn test, EKG

repeat TSH and liver fxn every 6 months

repeat EKG and physical every year

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

loading and maintenance dosing amiodarone

A

loading - total - 6-10g (400-800mg daily in 2-4 doses) - big dose 1st so it starts working

maintenance is 200mg QD

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

haloperidol + amiodarone

A

risk torsada

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

methadone + amiodarone

A

risk torsada

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

dofetilide brand

A

tikosyn

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

concern with dofetilide

A

risk for serious ventricular arrhythmias!!!

20
Q

contraindication to dofetlilide

A

creatinine clearance less than 20

21
Q

explain when dofetilide should be initiated and the monitoring parameters

A

initiate inpatient for 3 days – monitor EKG! for QT!

then monitor EKG every 3-6 months

22
Q

dronedarone brand name

23
Q

multaq (dronedarone) dosing

A

500mcg BID (adjust for renal)

24
Q

differentiate between dronedarone and amiodarone

A

dronedarone has a shorter half life, no iodine, and less noncardiac toxicities

HOWEVER, it is also less effective, increases serum creatinine, AND has an FDA warning of acute hepatic failure

25
Q

dronederone contraindications

does this also apply to amiodarone

A

NHYA class II-III with recent decompensation HF or NHYA class IV.
OR permanent afib

amiodarone CAN be used in these cases

26
Q

true or false

if hemodynamically unstable, CARDIOVERT

27
Q

patient has dizziness, palpitations, blurry vision, and is in afib.

has RVR on the EKG (rapid ventricular rate)

BP 89/42
HR = 155bpm
O2 sat = 82%

medical team decides antiarrhythmic approach. what is best?

A

DIRECT CARDIOVERSION NOW

this patient is not hemodynamically stable. we dont have time to wait 3 weeks for them to be anticoagulated

however, we can anticoagulate AFTER the cardioversion

if the patient was stable, then we could anticoagulate 1st bc we have the time

28
Q

patient with afib is being considered for amiodarone vs dronedarone
which would make dronedarone more desirable?

-history of class III HF with recent decompensation

-excellent kidney function

-history of liver disease

-pt desire to avoid serious ADR

-allergy to shellfish

A

i think it’s patient desire to avoid serious ADR

amiodarone doesnt need dose adjustment fir renal failoure

29
Q

define “sudden cardiac arrest

A

sudden cessation of cardiac activity. victim is unresponsive with non breathing or signs of circulation

30
Q

4 causes of sudden cardiac arrest

A

pulseless VT
VT
PEA (pulseless electrical activity)
asystole

31
Q

true or false

VT (ventricular tachycardia) can occur either with or without a pulse

A

TRUE

if with a pulse, perfusion is still happening

32
Q

what is PVC

A

“premature ventricular contractions”

there is an extra ventricular systolic beat

33
Q

“3 PVCs + HR over 100”

A

ventricular tachycardia (VT)

34
Q

“hallmark of long QTc

35
Q

“flatline”

36
Q

“chaotic asynchronous contraction”

A

ventricular fibrillation

37
Q

4 cardiac emergency arrhythmias

A

VT
VF
PEA
asystole

38
Q

“organized, electrical activity that fails to produce mechanical contraction to produce a pulse”

also called a non-perfusinf rhythm

A

PEA “pulseless electrical activitt”

39
Q

what does defibrillation do

A

try to get to NSR (AKA cardioversion! only dif is that defibrillation is working with a non-life sustaining rhythm)

40
Q

ONLY 2 cardiac emergencies that get defibrillation

A

for pulseless VT and VF

NOT FOR PEA OR ASYSTOLE

41
Q

TRUE OR FALSE

never interupt CPR to place an IV or give drugs

A

TRUE - just focus on CPR

42
Q

3 drugs that can potentially be used in cardiac arrest but do NOT increase survival

A

epinephrine
amiodarone
vasopressin (not rec in recent guidelines)

43
Q

when is amiodarone appropriate for cardiac arrest patient

A

only if failed defibrillation 3x and epinephrine once

44
Q

dose of epi for cardiac arrest

A

1mg IV/IO.repeat every 3-5 mins (no max)

45
Q

ventilation rate

A

2 breaths/30 secs or 1 breath/8 secs (if advanced airway available)

46
Q

asystole to vfib

A

have gone from a nonshockable rhythm to a shockable rhythm